Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease patent foramen ovale
Symptom C0038454|stroke
Sentences 66
PubMedID- 22845816 There is a higher risk of stroke with patent foramen ovale, especially when combined with atrial septal aneurysm.
PubMedID- 20938409 Recurrence of cryptogenic stroke or tia in patients with patent foramen ovale successfully treated by using different kind of percutaneous occluder devices: five-year follow-up.
PubMedID- 24477152 Interpretation: for stroke patients with patent foramen ovale, the choice between lifelong antithrombotic therapy alone and transcatheter closure is a difficult one.
PubMedID- 23743402 Shunt volume dynamics in stroke patients with patent foramen ovale.
PubMedID- 21804775 Finally, we need to consider the possibility that patent foramen ovale discovered in patients with cryptogenic stroke might be incidental as has been argued to be the case by kent d. et al.
PubMedID- 21331344 They also recommended that cryptogenic stroke patients with patent foramen ovale should be investigated for deep venous thrombosis in the legs and pelvic veins.
PubMedID- 22417252 Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
PubMedID- 23864310 Objective: we aimed to create an index to stratify cryptogenic stroke (cs) patients with patent foramen ovale (pfo) by their likelihood that the stroke was related to their pfo.
PubMedID- 24987042 patent foramen ovale (pfo) is associated with cryptogenic stroke, but uncertainty remains about the exact relationship and the best management.
PubMedID- 21190569 Several studies identified an increased frequency of patent foramen ovale (pfo) in patients with stroke of undetermined aetiology, also referred to as cryptogenic stroke (cs) .
PubMedID- 23306323 Letter by furlan regarding "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth.
PubMedID- 21789269 Whether or not the presence of a patent foramen ovale alone is associated with an increased stroke risk in pregnancy has not been properly examined, nor has the incidence of pregnancy-related stroke in association with peripartum cardiomyopathy.
PubMedID- 23323125 A case of cryptogenic stroke associated with patent foramen ovale coexisting with pulmonary embolisms, deep vein thromboses, and renal artery infarctions.
PubMedID- 22694008 Device closure for stroke with patent foramen ovale.
PubMedID- 21494544 Should patent foramen ovale be closed in patients with recent cryptogenic stroke or presumptive platypnea-orthodeoxia syndrome.
PubMedID- 22422892 Objective: to identify whether factors supporting a diagnosis of paradoxical embolism (i.e., venous thrombosis or valsalva maneuver) are associated with radiologic markers of recurrent strokes in patients with patent foramen ovale (pfo) and cryptogenic stroke (cs).
PubMedID- 25994249 D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
PubMedID- 23956892 Intracardiac shunting via a patent foramen ovale (pfo) is associated with cryptogenic stroke in individuals without scd.
PubMedID- 25248812 Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
PubMedID- 21871067 Background: as previously reported there is evidence for a reduction in right to left shunt (rls) in stroke patients with patent foramen ovale (pfo).
PubMedID- 24495982 Risk of stroke in patients with patent foramen ovale: an updated meta-analysis of observational studies.
PubMedID- 24582173 Purpose: to compare magnetic resonance imaging (mri) brain feature in cryptogenic stroke patients with patent foramen ovale (pfo), cryptogenic stroke patients without pfo and patients with cardioembolic stroke.
PubMedID- 26300647 In the closure or medical therapy for cryptogenic stroke with patent foramen ovale (closure) i trial, the 2-year rate of stroke recurrence was 7% in the medical group, while in the closure of patent foramen ovale versus medical therapy after cryptogenic stroke (respect) and percutaneous closure of patent foramen ovale in cryptogenic embolism (pc) trials (with more stringent criteria for ruling out alternative stroke mechanisms), the rates were closer to 1% per year.
PubMedID- 23015966 Cryptogenic stroke associated with patent foramen ovale in a collegiate volleyball athlete: a case report.
PubMedID- 22263185 Of the remaining cases, one each was caused by right atrial thrombosis, patent foramen ovale (pfo) with cerebral stroke (for which we performed thromboembolectomy with pfo primary closure) and steroid taking due to renal failure.
PubMedID- 22694009 Device closure for stroke with patent foramen ovale.
PubMedID- 21526565 In order to study anatomical and functional characteristics of patent foramen ovale (pfo) in patients with cryptogenic stroke and with other stroke subtypes we examined 56 stroke patients (male--35, female--21, age 46.7 +/- 16.5 years) with pfo and ischemic stroke.
PubMedID- 22180252 We synthesized the available evidence on secondary stroke prevention in patients with patent foramen ovale and cryptogenic stroke.
PubMedID- 24739592 Differential lesion patterns on t2-weighted magnetic resonance imaging and fluid-attenuated inversion recovery sequences in cryptogenic stroke patients with patent foramen ovale.
PubMedID- 24300230 A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack.
PubMedID- 23077982 Cardioembolic stroke in patients with patent foramen ovale and implanted cardiac leads.
PubMedID- 26056962 Recurrent stroke in patients with patent foramen ovale: an observational prospective study of percutaneous closure of pfo versus non-closure.
PubMedID- 22348793 Methods: this is a cohort study on the effect of a standardised treatment of stroke patients with a patent foramen ovale.
PubMedID- 24495944 Amplatzer pfo occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials.
PubMedID- 23117318 Background: the role of percutaneous closure of patent foramen ovale (pfo) in patients with cryptogenic stroke or transient ischemic attack remains controversial.
PubMedID- 23339957 Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale.
PubMedID- 24214884 Background: patent foramen ovale (pfo) is associated with cryptogenic stroke (cs), although the pathogenicity of a discovered pfo in the setting of cs is typically unclear.
PubMedID- 24607561 Pooled risk of non-fatal ischaemic stroke with patent foramen ovale closure versus medical therapy.
PubMedID- 23715857 Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.
PubMedID- 23847132 Background: in patients with cryptogenic stroke, transcatheter (tc) closure of a patent foramen ovale (pfo) has not been shown to better prevent recurrent vascular events than medical therapy.
PubMedID- 20446943 Prevention of stroke in patients with patent foramen ovale.
PubMedID- 21794121 Background: despite the diffusion into practice of percutaneous closure of a patent foramen ovale (pfo) in patients with cryptogenic stroke (cs), the benefits have not been demonstrated, and remain unclear.
PubMedID- 22867980 Thrombus through a patent foramen ovale: a direct cause of cardioembolic stroke and pulmonary embolism.
PubMedID- 23451348 Response to letter regarding article, "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth.
PubMedID- 24938843 Background and purpose: paradoxical embolization is frequently posited as a mechanism of ischemic stroke in patients with patent foramen ovale.
PubMedID- 25358696 Provoked right-to-left shunt in patent foramen ovale associates with ischemic stroke in posterior circulation.
PubMedID- 20884416 Aims: though the association of patent foramen ovale with cryptogenic stroke in young patients has been known for 20 years, most interventional closure systems are not specifically designed for pfo closure, but instead are adapted from asd closure systems.
PubMedID- 22989503 Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth.
PubMedID- 20854974 patent foramen ovale (pfo) is associated with cryptogenic stroke, migraine headache, decompression sickness, and platypnea-orthodeoxia syndrome.
PubMedID- 26448826 We reported the patient who had multiple thrombi which were accompanied with a cryptogenic ischemic stroke and associated with patent foramen ovale after operation.

Page: 1 2